Tag: cardiac myosin inhibitor

Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice, and not medical advice. Both trials discussed below are peer-reviewed, randomized, double-blind, placebo-controlled phase 3 trials published in the New England Journal of Medicine. The comparison drawn between them is an indirect, cross-trial…